Does Rallies show Form 4 insider transactions for PLSE?

Yes. Rallies tracks PLSE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PLSE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PLSE. It does not provide personalized investment advice.

PLSE (Pulse Biosciences, Inc Common Stock (DE)) Stock Analysis - Insider Trades

Pulse Biosciences, Inc Common Stock (DE) (PLSE) is a publicly traded Healthcare sector company. As of May 21, 2026, PLSE trades at $25.66 with a market cap of $1.77B and a P/E ratio of -23.50. PLSE moved +4.49% today. Year to date, PLSE is +78.70%; over the trailing twelve months it is +52.84%. Its 52-week range spans $12.56 to $27.98. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PLSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PLSE stock inside the company?

Recent PLSE insider activity includes DUGGAN ROBERT W bought 660.23K, LAVIOLETTE PAUL A bought 15.00K, LAVIOLETTE PAUL A bought 15.00K, DUGGAN ROBERT W bought 660.23K, and Danahy Kevin Patrick sold 5.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PLSE Key Metrics

Key financial metrics for PLSE
Metric	Value
Price	$25.66
Market Cap	$1.77B
P/E Ratio	-23.50
EPS	$-1.10
Dividend Yield	0.00%
52-Week High	$27.98
52-Week Low	$12.56
Volume	0
Avg Volume	0
Revenue (TTM)	$751.00K
Net Income	$-74.57M
Gross Margin	0.00%

Recent PLSE Insider Trades

DUGGAN ROBERT W bought 660.23K (~$13.00M) on May 11, 2026.
LAVIOLETTE PAUL A bought 15.00K (~$295.35K) on May 11, 2026.
LAVIOLETTE PAUL A bought 15.00K (~$295.35K) on May 11, 2026.
DUGGAN ROBERT W bought 660.23K (~$13.00M) on May 11, 2026.
Danahy Kevin Patrick sold 5.00K (~$118.20K) on Feb 18, 2026.

Latest PLSE News

Pulse Biosciences Grants Executive Options and RSUs Under Nasdaq Rule — Feb 20, 2026
Pulse Biosciences Beats Q4 Loss Estimates and Targets 2026 IDE Enrollment — Feb 20, 2026
Pulse Biosciences Shares Jump 51% on nPulse Catheter AF Data — Feb 9, 2026

PLSE Analyst Consensus

2 analysts cover PLSE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.

Common questions about PLSE

Who is trading PLSE stock inside the company?: Recent PLSE insider activity includes DUGGAN ROBERT W bought 660.23K, LAVIOLETTE PAUL A bought 15.00K, LAVIOLETTE PAUL A bought 15.00K, DUGGAN ROBERT W bought 660.23K, and Danahy Kevin Patrick sold 5.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PLSE?: Yes. Rallies tracks PLSE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PLSE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PLSE. It does not provide personalized investment advice.